One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Blood pressure control in patients with ischemic cardiomyopathy
Johann Auer, MD, FESC, FACC, FAHA, FSCAI 1,2,3 , and Gudrun Lamm, MD, FESC 4 Braunau, Austria
doi : 10.1016/j.ahj.2023.01.015
Volume 258, April 2023, Pages 186-189
Design and pilot implementation for the BETTER CARE-HF trial: A pragmatic cluster-randomized controlled trial comparing two targeted approaches to ambulatory clinical decision support for cardiologists
Amrita Mukhopadhyay, MD a , Harmony R. Reynolds, MD a , Yuhe Xia, MS b , Lawrence M. Phillips, MD a , Rod Aminian, MPH c , Ruth-Ann Diah, MSc c , Arielle R. Nagler, MD d , Adam Szerencsy, DO c,e , Archana Saxena, MD a,c , Leora I. Horwitz, MD e,f , Stuart D. Katz, MD a , and Saul Blecker, MD e,f New York, NY
doi : 10.1016/j.ahj.2022.12.016
Volume 258, April 2023, Pages 38-48
Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial
Christian Spaulding, MD, PhD a,∗, Florian Krackhardt, MD b,∗, Kris Bogaerts, PhD c,d , Philip Urban, MD e , Susanne Meis, BA f , Marie-Claude Morice, MD g , and Simon Eccleshall, MD h Paris, France; Berlin, Germany
doi : 10.1016/j.ahj.2023.01.007
Volume 258, April 2023, Pages 77-84
Prehospital treatment with zalunfiban (RUC-4) in patients with ST‐ elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial
Sem A.O.F. Rikken, MD a,b,∗, Abi Selvarajah, MD c,∗, Renicus S. Hermanides, MD, PhD c , Barry S. Coller, MD, PhD d , C. Michael Gibson, MS, MD e , Christopher B. Granger, MD f , Frédéric Lapostolle, MD, PhD g , Sonja Postma, PhD h , Henri van de Wetering, MSc h,i , Risco C.W. van Vliet, MSc j , Gilles Montalescot, MD, PhD k , Jurriën M. ten Berg, MD, PhD a,b,m , and Arnoud W.J. van ’t Hof, MD PhD a,l,m , on behalf of the CELEBRATE investigators∗∗ Maastricht, The Netherlands, Boston
doi : 10.1016/j.ahj.2022.12.015
Volume 258, April 2023, Pages 119-128
Early and complete restoration of target vessel patency in ST-elevation myocardial infarction (STEMI) is associated with improved outcomes. Oral P2Y12 inhibitors have failed to demonstrate either improved patency or reduced mortality when administered in the prehospital setting.
βeta blocker interruption after uncomplicated myocardial infarction: rationale and design of the randomized ABYSS trial
Johanne Silvain, MD,PhD a , Guillaume Cayla, MD,PhD b , Emile Ferrari, MD,PhD c , Grégoire Range, MD d , Etienne Puymirat, MD,PhD e,f , Nicolas Delarche, MD g , Jean-Philippe Collet, MD,PhD a , Raphaelle Dumaine, MD h , Michel Slama, MD i , Laurent Payot, MD j , Mohamad E. Kasty, MD k , Karim Aacha, MD a , Eric Vicaut, MD,PhD l , and Gilles Montalescot, MD,PhD a , on behalf of the ABYSS investigators of the ACTION Study Group, Paris, France; Nimes, France; Chartres, France; Pau, France; Villeneuve St Denis
doi : 10.1016/j.ahj.2023.01.014
Volume 258, April 2023, Pages 168-176
Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making
Raquel López-Galvez, PhD a,∗, José Miguel Rivera-Caravaca, RN, PhD a,b,c,∗, Vanessa Roldán, MD, PhD d , Esteban Orenes-Piñero, PhD e , MarÃa Asunción Esteve-Pastor, MD, PhD a , Cecilia López-GarcÃa, RN, PhD a , Daniel Saura, MD, PhD a , Josefa González, MD, PhD a , Gregory Y.H. Lip, MD c,f,∗∗, and Francisco MarÃn, MD, PhD a,∗∗ Murcia, Spain; Liverpool
doi : 10.1016/j.ahj.2022.12.007
Volume 258, April 2023, Pages 1-16
The 2020 ESC atrial fibrillation (AF) guidelines suggest the novel 4S-AF scheme for the characterization of AF. Imaging techniques could be helpful for this objective in everyday clinical practice, and information derived from these techniques reflects basic aspects of the pathophysiology of AF, which may facilitate treatment decision-making, and optimal management of AF patients.
Pursuing functional biomarkers in complex disease: Focus on pulmonary arterial hypertension
Giuditta Benincasa, BiolD, PhD a,1 , Claudio Napoli, MD, PhD, MBEth a,1 , Joseph Loscalzo, MD, PhD b,1 , and Bradley A. Maron, MD b,1 Naples, Italy; Boston, MA
doi : 10.1016/j.ahj.2022.12.009
Volume 258, April 2023, Pages 96-113
Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarction
Ronak Delewi, MD, PhD a,# , Rosanne F. Vogel, MD a,b,# , Jeroen M. Wilschut, MD c , Miguel E. Lemmert, MD, PhD c,d , Roberto Diletti, MD, PhD c , Ria van Vliet e , Nancy W.P.L. van der Waarden, MSc f , Rutger-Jan Nuis, MD, PhD c , Valeria Paradies, MD e , Dimitrios Alexopoulos, MD, PhD g , Felix Zijlstra, MD, PhD c , Gilles Montalescot, MD, PhD h , Dominick J. Angiolillo, MD, PhD i , Mitchell W. Krucoff, MD, PhD j , Pieter A. Doevendans, MD, PhD b , Nicolas M. Van Mieghem, MD, PhD c , Pieter C. Smits, MD, PhD e , and Georgios J. Vlachojannis, MD, PhD b,e Amsterdam, the Netherlands
doi : 10.1016/j.ahj.2022.12.013
Volume 258, April 2023, Pages 17-26
Association of ACEI/ARB and statin prescribing patterns with mortality after Transcatheter Aortic Valve Replacement (TAVR): Findings from real-world claims data
Robert J. Cubeddu, MD a , Shannon M.E. Murphy, MA b , Craig R. Asher, MD c , Santiago A. Garcia, MD d , Juan F. Granada, MD e , Creighton W. Don, MD f,g , Sankalp Patel, DO a , Mazen S. Albaghdadi, MD a , João L. Cavalcante, MD h , Megan Coylewright, MD i , Rebecca T. Hahn, MD j , Philippe Genereux, MD k , Pradeep K. Yadav, MD l , Vinod H. Thourani, MD l , and Martin B. Leon, MD j Naples, FL; Irvine, CA; Weston, FL; Minneapolis, MN; New York, NY; Seattle, WA; Chattanooga, TN; Morristown, NJ; Atlanta, GA
doi : 10.1016/j.ahj.2022.12.012
Volume 258, April 2023, Pages 27-37
Outcomes in patients with cardiometabolic disease who develop hyperkalemia while treated with a renin-angiotensin-aldosterone system inhibitor
Matthew Johnson, BA a,b , Fritha J. Morrison, PhD a , Gearoid McMahon, MBBCh a,c , Maxwell Su, ScD d,e , and Alexander Turchin, MD MS a,c Boston, MA; New York, NY; Wellesley Hills, MA
doi : 10.1016/j.ahj.2023.01.002
Volume 258, April 2023, Pages 49-59
Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial
Kelley R.H. Branch, MD, MSc a,# , Jeffrey L. Probstfield, MD a,# , Jackie Bosch, PhD b,# , Deepak L. Bhatt, MD, MPH c,# , Aldo P. Maggioni, MD d,# , Eva Muehlhofer, MD e,# , Alvaro Avezum, MD f,# , Petr Widimsky, MD g,# , Stuart J. Connolly, MD b,# , Quilong Yi, PhD b,# , Olga Shestakovska, MSc b,# , Salim Yusuf, DPhil b,# , and John W. Eikelboom, MBBS b,# Seattle, WA; Hamilton, Ontario; Boston, MA; Firenze, Italy; Wuppertal, Germany; Prague, Czech Republic
doi : 10.1016/j.ahj.2023.01.008
Volume 258, April 2023, Pages 60-68
Low dose rivaroxaban with aspirin reduced major cardiovascular events (MACE) compared to aspirin alone in patients with cardiovascular disease although effects on total events are unknown.
Characteristics and outcomes of patients with no standard modifiable risk factors undergoing primary revascularization for acute myocardial infarction: Insights from the nationwide Japanese percutaneous coronary intervention registry
Yuichi Saito, MD a , Taku Inohara, MD b , Shun Kohsaka, MD b , Hideki Wada, MD c , Itaru Takamisawa, MD d , Kyohei Yamaji, MD e , Tetsuya Amano, MD f , Yoshio Kobayashi, MD a , and Ken Kozuma, MD g , J-PCI Registry Investigators Chiba, Japan; Tokyo, Japan; Izunokuni, Japan; Kyoto, Japan; Nagakute, Japan
doi : 10.1016/j.ahj.2023.01.009
Volume 258, April 2023, Pages 69-76
Feasibility and outcomes from using a commitment device and text message reminders to increase adherence to time-restricted eating: A randomized trial
Alexander C. Fanaroff, MD, MHS a,b,c,d,e,f , Samantha Coratti, BA e , Rim Halaby, MD g , Monika Sanghavi, MD a , Rupal P. O’Quinn, MD a,f , Sheela Krishnan, MD a , Helene Glassberg, MD a , Archna Bajaj, MD, MSCE h , Srinath Adusumalli, MD, MSHP, MBMI a,b,f,i , Neel Chokshi, MD, MBA a,f , and Mitesh S. Patel, MD, MBA j Philadelphia, PA; Bethesda, MD; Woonsocket, RI; St. Louis, MO
doi : 10.1016/j.ahj.2022.12.010
Volume 258, April 2023, Pages 85-95
Public reporting of black participation in anti-hypertensive drug clinical trials
Michael D. Green, BA a,f , Mahalia R. Dalmage, BA b , Jay B. Lusk, BSC c,d , Emilie F. Kadhim, MPH, BA e , Lesley A. Skalla, PhD, MSLS f , and Emily C. O’Brien, PhD a Durham, NC; Chicago, IL; Ontario, Canada
doi : 10.1016/j.ahj.2023.01.001
Volume 258, April 2023, Pages 129-139
Mortality and rehospitalization after mitral valve surgery as a function of age and key comorbidities
Eva Havers-Borgersen, MD a , Jawad H. Butt, MD a , Jarl Strange, MD a , Christian L. Carranza, MD, PhD b , Lars Køber, MD, DMSc a , and Emil L. Fosbøl, MD, PhD a Copenhagen, Denmark; Rigshospitalet, Denmark
doi : 10.1016/j.ahj.2023.01.006
Volume 258, April 2023, Pages 140-148
Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry
Ankeet S. Bhatt, MD, MBA a,b , Lori B. Daniels, MD, MAS c , James de Lemos, MD d , Erica Goodrich, MS e , Erin A. Bohula, MD, DPhil a,e , and David A. Morrow, MD, MPH a,e , On behalf of the AHA COVID-19 CVD Registry Investigators Boston, MA; San Francisco, CA; La Jolla, CA; Dallas, TX
doi : 10.1016/j.ahj.2022.12.014
Volume 258, April 2023, Pages 149-156
Evaluation of the association between circulating IL-1β and other inflammatory cytokines and incident atrial fibrillation in a cohort of postmenopausal women
Sofia E. Gomez, MD a , Justin Parizo, MD b , Simon Ermakov, MD c , Joseph Larson, MS d , Robert Wallace, MD e , Themistocles Assimes, MD, PhD b , Mark Hlatky, MD, PhD b,f , Marcia Stefanick, PhD g , and Marco V. Perez, MD b Seattle, WA; Stanford, CA
doi : 10.1016/j.ahj.2023.01.010
Volume 258, April 2023, Pages 157-167
Systolic blood pressure time in target range and long-term outcomes in patients with ischemic cardiomyopathy
Guangguo Fu, MD∗, Zhuoming Zhou, MD∗, Bohao Jian, MD, Suiqing Huang, MD, PhD, Zicong Feng, MD, PhD, Mengya Liang, MD, PhD, Quan Liu, MD, Yang Huang, MD, Kaizheng Liu, MD, Guangxian Chen, MD, PhD, and Zhongkai Wu, MD, PhD Guangzhou, China
doi : 10.1016/j.ahj.2022.12.011
Volume 258, April 2023, Pages 177-185
Trends in outcomes and resource utilization for acute myocardial infarction admissions during the COVID-19 pandemic
Fouad Chouairi, MD a , Bret Pinsker, MD a , Marat Fudim, MD MHS b,c , and P. Elliott Miller, MD MHS d Durham, NC; New Haven, CT
doi : 10.1016/j.ahj.2023.01.003
Volume 258, April 2023, Pages 114-118
Some inquiries about the currently launched BROKEN SWEDEHEART therapeutic trial for takotsubo syndrome
John E. Madias, MD, FACC, FAHA 1,2 New York, NY
doi : 10.1016/j.ahj.2023.01.017
Volume 258, April 2023, Pages 190-191
